Advanced Accelerator Applications

  • Company
    • About Us
    • Our Purpose
    • History
    • Our Business
    • Manufacturing Expertise
    • Our Sites
    • Board of Directors
    • Corporate Executive Team
    • Corporate Social Responsibility
    • Code of Conduct
    • Careers
  • Products
    • Products Home
    • Special Programs
    • Support Services
    • SPC
  • Research & Development
    • R&D Home
    • Pipeline
    • Clinical Trials
    • Partnering
    • Scientific publications
    • Netter-1 study
  • Investor Relations
    • IR Home
    • News & Events
    • Stock Information
    • Corporate Governance
    • Financial Information
    • Shareholder Services
  • Press Room
    • Press Room Home
    • News
    • Press releases
    • Conferences & Events
    • Photo Gallery
  • Nuclear Medicine
    • About Nuclear Medicine
    • Diagnostics
    • Therapy
    • Glossary
  • Contact us
  • English
  • Français
  • Italiano
  • Español
Home > Investor Relations > SEC Filings
AAAP (Common Stock)
$81.63
0.00 (0.00%)
02/09/18 4:00 p.m. ET
Print Page  E-mail Page  RSS  E-mail Alerts  Tearsheet 

SEC Filings

Form 6-K
ADVANCED ACCELERATOR APPLICATIONS S.A. filed this Form 6-K on 09/06/2016
Document Outline
Entire Document (41.2 KB)
Subdocument 1 - 6-K - FORM 6-K
Page 1 - UNITED STATES
Page 2 - SIGNATURE
Page 3 - ADVANCED ACCELERATOR APPLICATIONS S.A.
Subdocument 2 - EX-99.1 - EXHIBIT 99.1
Page 1 - EXHIBIT 99.1
Page 2 - Anthracyclines continue to play an important role in the treatment of breast cancer. Anthracycline b
Page 3 - Cautionary Statement Regarding Forward-Looking Statements

Investor Home

News & Events

  • Event Calendar
  • Presentations
  • Press Room

Corporate Governance

  • Governance Documents
  • Governance Committees
  • Committee Composition

Financial Information

  • SEC Filings
  • Annual Reports
  • Homepage
  •  Contact us
  •  Careers
  •  Site map
  •  Disclaimer

© -20 Advanced Accelerator Applications - All rights reserved